hu.MAP 2.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: HuMAP2_01100
Confidence: High
Proteins| Genename | Protein Name | Links |
|---|---|---|
| RNASEH2A | Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Aicardi-Goutieres syndrome 4 protein) (AGS4) (RNase H(35)) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A) | UniProt NCBI |
| RNASEH2C | Ribonuclease H2 subunit C (RNase H2 subunit C) (Aicardi-Goutieres syndrome 3 protein) (AGS3) (RNase H1 small subunit) (Ribonuclease HI subunit C) | UniProt NCBI |
| RNASEH2B | Ribonuclease H2 subunit B (RNase H2 subunit B) (Aicardi-Goutieres syndrome 2 protein) (AGS2) (Deleted in lymphocytic leukemia 8) (Ribonuclease HI subunit B) | UniProt NCBI |
Enrichments
| Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
|---|---|---|---|---|
| HP:0009704 | 2.07754912471e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Chronic CSF lymphocytosis |
| HP:0009709 | 2.07754912471e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Increased CSF interferon alpha |
| HP:0012229 | 2.07754912471e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | CSF pleocytosis |
| HP:0009710 | 2.07754912471e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Chilblains |
| HP:0200149 | 2.07754912471e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | CSF lymphocytic pleiocytosis |
| HP:0030356 | 2.07754912471e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Increased serum interferon-gamma level |
| HP:0001955 | 3.32407859954e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Unexplained fevers |
| HP:0040140 | 3.32407859954e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Degeneration of the striatum |
| HP:0005550 | 3.32407859954e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Chronic lymphatic leukemia |
| HP:0030355 | 4.98611789931e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal serum interferon-gamma level |
| HP:0030354 | 4.98611789931e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal serum interferon level |
| HP:0007052 | 7.12302557044e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Multifocal cerebral white matter abnormalities |
| HP:0011834 | 7.12302557044e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Moyamoya phenomenon |
| GO:0032299 | 9.08185760231e-08 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | ribonuclease H2 complex |
| HP:0004809 | 1.30588802125e-07 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Neonatal alloimmune thrombocytopenia |
| HP:0003683 | 1.69765442762e-07 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Large beaked nose |
| HP:0007076 | 1.69765442762e-07 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Extrapyramidal muscular rigidity |
| KEGG:03030 | 2.14716765829e-07 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | DNA replication |
| HP:0011112 | 2.1606510897e-07 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of serum cytokine level |
| HP:0030038 | 2.70081386213e-07 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Enchondroma |
| HP:0011111 | 2.70081386213e-07 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of immune serum protein physiology |
| HP:0004963 | 3.32407859954e-07 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Calcification of the aorta |
| HP:0005558 | 3.32407859954e-07 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Chronic leukemia |
| HP:0030880 | 4.8436573879e-07 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Raynaud phenomenon |
| HP:0012490 | 6.76687429192e-07 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Panniculitis |
| HP:0001063 | 7.89468667391e-07 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Acrocyanosis |
| HP:0003207 | 1.20141697955e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Arterial calcification |
| HP:0002132 | 1.36524656767e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Porencephalic cyst |
| HP:0004934 | 1.36524656767e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Vascular calcification |
| HP:0011915 | 1.73623748279e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Cardiovascular calcification |
| HP:0000625 | 1.73623748279e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Eyelid coloboma |
| HP:0002139 | 2.1689612862e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Arrhinencephaly |
| HP:0010994 | 2.1689612862e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal corpus striatum morphology |
| HP:0025323 | 2.40995698467e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal arterial physiology |
| HP:0100614 | 2.40995698467e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Myositis |
| HP:0006579 | 2.66816666159e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Prolonged neonatal jaundice |
| HP:0011226 | 2.66816666159e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Aplasia/Hypoplasia of the eyelid |
| HP:0007108 | 3.23860229269e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Demyelinating peripheral neuropathy |
| HP:0002371 | 3.55201541779e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Loss of speech |
| HP:0001087 | 4.61215905686e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Developmental glaucoma |
| HP:0002313 | 5.00748697602e-06 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Spastic paraparesis |
| HP:0002828 | 1.09362185925e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Multiple joint contractures |
| HP:0000961 | 1.2361417292e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Cyanosis |
| HP:0002385 | 1.39053330844e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Paraparesis |
| HP:0002323 | 1.83156730835e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Anencephaly |
| HP:0001357 | 1.92968698558e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Plagiocephaly |
| HP:0000965 | 2.0312494585e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Cutis marmorata |
| HP:0001609 | 2.13631408567e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Hoarse voice |
| HP:0001433 | 2.13631408567e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Hepatosplenomegaly |
| HP:0010622 | 2.47311447806e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Neoplasm of the skeletal system |
| HP:0002180 | 2.84357116627e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Neurodegeneration |
| HP:0003552 | 2.9748129124e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Muscle stiffness |
| HP:0001640 | 3.24928683105e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Cardiomegaly |
| HP:0002510 | 3.69186415316e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Spastic tetraplegia |
| HP:0100578 | 4.00818584703e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Lipoatrophy |
| HP:0025454 | 6.29170912782e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal CSF metabolite level |
| HP:0004942 | 6.29170912782e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Aortic aneurysm |
| HP:0002415 | 7.95665699637e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Leukodystrophy |
| HP:0002187 | 9.31032864748e-05 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Intellectual disability, profound |
| HP:0009125 | 0.000101918624204 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Lipodystrophy |
| HP:0009145 | 0.00011127353112 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal cerebral artery morphology |
| HP:0002514 | 0.000114514507754 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Cerebral calcification |
| HP:0000958 | 0.000162534978223 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Dry skin |
| HP:0001909 | 0.000170940741981 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Leukemia |
| HP:0002960 | 0.000184085098501 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Autoimmunity |
| HP:0008936 | 0.000184085098501 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Muscular hypotonia of the trunk |
| HP:0000737 | 0.000197886554129 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Irritability |
| HP:0002617 | 0.000243393783742 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Dilatation |
| HP:0030163 | 0.000277311257167 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal vascular physiology |
| HP:0000952 | 0.000307872004791 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Jaundice |
| HP:0002063 | 0.000314241770407 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Rigidity |
| HP:0002061 | 0.000397654774179 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Lower limb spasticity |
| HP:0001369 | 0.000412850562063 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Arthritis |
| HP:0002134 | 0.000412850562063 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the basal ganglia |
| HP:0010766 | 0.000469077351574 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Ectopic calcification |
| HP:0004374 | 0.000486030746017 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Hemiplegia/hemiparesis |
| HP:0009124 | 0.000503387778576 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal adipose tissue morphology |
| HP:0000054 | 0.000557928191783 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Micropenis |
| HP:0011119 | 0.000567384601813 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the nasal dorsum |
| HP:0010551 | 0.000576947263642 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Paraplegia/paraparesis |
| HP:0011400 | 0.000586616770854 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal CNS myelination |
| HP:0002355 | 0.000586616770854 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Difficulty walking |
| HP:0002910 | 0.000667890492612 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Elevated hepatic transaminase |
| HP:0001396 | 0.000678548319622 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Cholestasis |
| HP:0001005 | 0.000722313375898 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Dermatological manifestations of systemic disorders |
| HP:0001679 | 0.000803358567253 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal aortic morphology |
| HP:0002071 | 0.000852281881213 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of extrapyramidal motor function |
| HP:0000821 | 0.000852281881213 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Hypothyroidism |
| HP:0007700 | 0.000877471273971 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Ocular anterior segment dysgenesis |
| HP:0004377 | 0.000903152155495 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Hematological neoplasm |
| HP:0002926 | 0.000942605406959 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of thyroid physiology |
| HP:0001639 | 0.00101088554291 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Hypertrophic cardiomyopathy |
| HP:0100659 | 0.00103909509851 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the cerebral vasculature |
| HP:0001945 | 0.00106782463497 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Fever |
| HP:0002315 | 0.00128388974394 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Headache |
| HP:0000501 | 0.0015272953994 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Glaucoma |
| HP:0001873 | 0.00167928651902 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Thrombocytopenia |
| HP:0002376 | 0.00169896565791 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Developmental regression |
| HP:0004297 | 0.00184104093235 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the biliary system |
| HP:0011873 | 0.00201286255516 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal platelet count |
| HP:0003819 | 0.00223433522771 | 0.666666666667 | RNASEH2C RNASEH2A | Death in childhood |
| HP:0004370 | 0.00224225959366 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of temperature regulation |
| HP:0000820 | 0.00238792309223 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the thyroid gland |
| HP:0007256 | 0.00264448260157 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal pyramidal sign |
| HP:0001872 | 0.00275204266203 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal thrombocyte morphology |
| HP:0000819 | 0.00289054395839 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Diabetes mellitus |
| HP:0004302 | 0.00300463227178 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Functional motor deficit |
| HP:0001952 | 0.00312168376381 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Glucose intolerance |
| HP:0002079 | 0.00318133257352 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Hypoplasia of the corpus callosum |
| HP:0011004 | 0.00333376828866 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal systemic arterial morphology |
| HP:0001608 | 0.00342752570631 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the voice |
| HP:0008736 | 0.00399218515726 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Hypoplasia of penis |
| HP:0100851 | 0.00402720432531 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal emotion/affect behavior |
| HP:0001332 | 0.00435163677096 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Dystonia |
| HP:0010549 | 0.00461568495452 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Weakness due to upper motor neuron dysfunction |
| HP:0012447 | 0.00509281251216 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal myelination |
| HP:0030962 | 0.00568972146137 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal morphology of the great vessels |
| HP:0025408 | 0.00573405695328 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal spleen morphology |
| HP:0002921 | 0.00586844410879 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the cerebrospinal fluid |
| HP:0000050 | 0.0060970605824 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Hypoplastic male external genitalia |
| HP:0001638 | 0.00633153871247 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Cardiomyopathy |
| HP:0011276 | 0.00647507005206 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Vascular skin abnormality |
| HP:0001743 | 0.00657195269718 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the spleen |
| HP:0001337 | 0.00671908116468 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Tremor |
| HP:0003241 | 0.00701989306396 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | External genital hypoplasia |
| HP:0001637 | 0.007329551761 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal myocardium morphology |
| HP:0010987 | 0.0074877387257 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal cellular immune system morphology |
| HP:0001881 | 0.0074877387257 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal leukocyte morphology |
| HP:0032251 | 0.00808721315129 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal immune system morphology |
| HP:0011014 | 0.00950443643655 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal glucose homeostasis |
| HP:0002119 | 0.0110094432953 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Ventriculomegaly |
| HP:0009830 | 0.0113563554161 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Peripheral neuropathy |
| HP:0100763 | 0.0124406609515 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the lymphatic system |
| HP:0003271 | 0.0132005809345 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Visceromegaly |
| HP:0000508 | 0.0135130087077 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Ptosis |
| HP:0000036 | 0.0141525756763 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the penis |
| HP:0000369 | 0.0144797908506 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Low-set ears |
| HP:0007370 | 0.0148120111376 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Aplasia/Hypoplasia of the corpus callosum |
| HP:0012444 | 0.0151492745266 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Brain atrophy |
| HP:0001371 | 0.0156647085286 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Flexion contracture |
| HP:0000253 | 0.0166709261154 | 0.666666666667 | RNASEH2C RNASEH2A | Progressive microcephaly |
| HP:0100261 | 0.0170041519362 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal tendon morphology |
| HP:0000357 | 0.0172808874154 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal location of ears |
| HP:0001438 | 0.0175606092232 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of abdomen morphology |
| HP:0001273 | 0.0191035562841 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal corpus callosum morphology |
| HP:0025015 | 0.0202151346972 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal vascular morphology |
| GO:0004523 | 0.020283420769 | 0.666666666667 | RNASEH2B RNASEH2A | RNA-DNA hybrid ribonuclease activity |
| HP:0002118 | 0.022676974613 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the cerebral ventricles |
| HP:0002648 | 0.022676974613 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of calvarial morphology |
| HP:0007367 | 0.0227883181872 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Atrophy/Degeneration affecting the central nervous system |
| HP:0011344 | 0.0237990042853 | 0.666666666667 | RNASEH2C RNASEH2A | Severe global developmental delay |
| HP:0001257 | 0.0255710895815 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Spasticity |
| HP:0410042 | 0.0269188182549 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal liver morphology |
| HP:0011793 | 0.027043635032 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Neoplasm by anatomical site |
| HP:0002500 | 0.0293567877248 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the cerebral white matter |
| HP:0002664 | 0.0308333096044 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Neoplasm |
| HP:0010938 | 0.0316591597185 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the external nose |
| HP:0011354 | 0.0333548375065 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Generalized abnormality of skin |
| HP:0012647 | 0.0343713906034 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal inflammatory response |
| HP:0012649 | 0.0343713906034 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Increased inflammatory response |
| HP:0000759 | 0.0348133037034 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal peripheral nervous system morphology |
| HP:0002683 | 0.0355582148779 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the calvaria |
| HP:0010993 | 0.0409072271866 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormality of the cerebral subcortex |
| HP:0000639 | 0.04291596551 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Nystagmus |
| HP:0004305 | 0.0430862669604 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Involuntary movements |
| HP:0001288 | 0.0432570183486 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Gait disturbance |
| HP:0012547 | 0.0446392984448 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Abnormal involuntary eye movements |
| HP:0001276 | 0.0448141259844 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Hypertonia |
| HP:0002650 | 0.0451651492781 | 1.0 | RNASEH2C RNASEH2A RNASEH2B | Scoliosis |
Edges
| Protein 1 | Protein 2 | Score | Precision | Evidence |
|---|---|---|---|---|
| RNASEH2C | RNASEH2A | 1.0 | 0.949 | hein_WMM hein (RNASEH2A) fraction |
| RNASEH2B | RNASEH2A | 1.0 | 0.949 | hein_WMM hein (RNASEH2A,RNASEH2B) fraction |
| RNASEH2C | RNASEH2B | 1.0 | 0.949 | hein_WMM hein (RNASEH2B) fraction |
Images
Click to enlarge
Complex HuMAP2_01100 has an average edge precision of 0.949 which is ranked 5 out of all 6965 complexes.
Related Complexes
| Genename | Complexes |
|---|---|
| RNASEH2A | HuMAP2_00183 HuMAP2_01100 HuMAP2_01825 HuMAP2_02047 HuMAP2_03593 HuMAP2_04588 HuMAP2_05586 |
| RNASEH2C | HuMAP2_00183 HuMAP2_00457 HuMAP2_01100 HuMAP2_01825 HuMAP2_02047 HuMAP2_03593 HuMAP2_04588 |
| RNASEH2B | HuMAP2_00183 HuMAP2_01100 HuMAP2_01825 HuMAP2_02047 HuMAP2_03593 HuMAP2_05586 |